Skip to Content

Novonesis AS Class B NVZMF

Morningstar Rating
$62.50 −2.90 (4.43%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NVZMF is trading at a 294% premium.
Price
$62.69
Fair Value
$29.95
Uncertainty
Medium
1-Star Price
$97.22
5-Star Price
$11.85
Economic Moat
Jtrl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NVZMF is a good fit for your portfolio.

Trading Information

Previous Close Price
$65.40
Day Range
$61.0062.50
52-Week Range
$38.8565.40
Bid/Ask
$62.20 / $65.02
Market Cap
$29.02 Bil
Volume/Avg
492 / 606

Key Statistics

Price/Earnings (Normalized)
34.44
Price/Sales
6.69
Dividend Yield (Trailing)
1.41%
Dividend Yield (Forward)
1.41%
Total Yield
1.41%

Company Profile

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Sector
Basic Materials
Industry
Specialty Chemicals
Stock Style Box
Large Growth
Total Number of Employees
6,756

Competitors

Valuation

Metric
NVZMF
IFF
DSFIR
Price/Earnings (Normalized)
34.4437.0663.39
Price/Book Value
8.351.711.20
Price/Sales
6.692.162.27
Price/Cash Flow
27.7223.5823.07
Price/Earnings
NVZMF
IFF
DSFIR

Financial Strength

Metric
NVZMF
IFF
DSFIR
Quick Ratio
0.760.751.20
Current Ratio
1.301.681.96
Interest Coverage
23.08−5.87−3.42
Quick Ratio
NVZMF
IFF
DSFIR

Profitability

Metric
NVZMF
IFF
DSFIR
Return on Assets (Normalized)
11.42%1.21%1.31%
Return on Equity (Normalized)
23.56%2.46%2.01%
Return on Invested Capital (Normalized)
19.08%2.46%1.93%
Return on Assets
NVZMF
IFF
DSFIR
See how this stock stacks up to its competitors with Morningstar Investor

Specialty Chemicals Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Linde PLC
LIN
KkvpjtlfWqqsx$212.8 Bil
Sherwin-Williams Co
SHW
MqzrslqhlJqz$76.4 Bil
Ecolab Inc
ECL
TfzdbfjzBhrn$69.7 Bil
Air Products & Chemicals Inc
APD
WlcqlfrgcRnv$60.7 Bil
DuPont de Nemours Inc
DD
RvgzlwxwSnldl$33.4 Bil
LyondellBasell Industries NV Class A
LYB
FbmlkqkrFyhrzyc$31.0 Bil
PPG Industries Inc
PPG
JmlfwnmSsfqhq$30.2 Bil
International Flavors & Fragrances Inc
IFF
NqxlxjglKsjll$24.5 Bil
Sociedad Quimica Y Minera De Chile SA ADR
SQM
HqdyfpgvGfbxdg$11.7 Bil
Eastman Chemical Co
EMN
DftsnwywZrtbm$11.6 Bil

Sponsor Center